{"id":"W2127685474","doi":"10.1200/jco.2007.15.2280","title":"Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"American Society of Clinical Oncology; AstraZeneca","keywords":"Medicine; Erlotinib; Lung cancer; Internal medicine; Placebo; Hazard ratio; Cancer; Clinical trial; Chemotherapy; Quality of life (healthcare); Surgery; Gastroenterology; Epidermal growth factor receptor; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02099396,0.001239949,0.004308821,0.0008923681,0.0009538798,0.00164006,0.001084958,0.0009272865,0.002025675],"category_scores_gemma":[0.01941724,0.0005821324,0.004770509,0.003279614,0.0007868441,0.0004322897,0.0008759058,0.001485731,0.0002266368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006599781,"about_ca_system_score_gemma":0.01242552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.204957,"about_ca_topic_score_gemma":0.368351,"domain_scores_codex":[0.9859871,0.008123597,0.001009584,0.0008542455,0.00327885,0.0007466489],"domain_scores_gemma":[0.9820195,0.006334664,0.00500205,0.001420457,0.003213274,0.002010024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5137872,0.001034833,0.2842814,0.008099287,0.104885,0.0003997497,0.0004294498,0.003648995,0.001574127,0.0008692595,0.01965428,0.06133644],"study_design_scores_gemma":[0.1303146,0.007706603,0.7932953,0.0008677645,0.05023173,0.0003222964,0.0001664066,0.00238448,0.0002594708,0.0003714788,0.01392734,0.0001524687],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8069618,0.1471266,0.001965933,0.002019903,0.0003068094,0.00617298,0.02979378,0.00009747582,0.005554855],"genre_scores_gemma":[0.9579718,0.01888239,0.001481465,0.001751895,0.0003313819,0.002600284,0.0151768,0.00006050436,0.001743606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.204957,"threshold_uncertainty_score":0.407528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.22132737951902,"score_gpt":0.5780171170297974,"score_spread":0.3566897375107774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}